Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16216317)

  • 1. The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.
    Ødegaard E; Staff AC; Kaern J; Flørenes VA; Kopolovic J; Tropé CG; Abeler VM; Reich R; Davidson B
    Gynecol Oncol; 2006 Mar; 100(3):462-8. PubMed ID: 16216317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
    Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
    Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study.
    Davidson B; Nesland JM; Goldberg I; Kopolovic J; Gotlieb WH; Bryne M; Ben-Baruch G; Berner A; Reich R
    Gynecol Oncol; 2001 May; 81(2):166-71. PubMed ID: 11330944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
    Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
    Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
    Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
    Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F
    Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
    Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
    Davidson B; Alejandro E; Flørenes VA; Goderstad JM; Risberg B; Kristensen GB; Trope CG; Kohn EC
    Cancer; 2004 May; 100(10):2139-47. PubMed ID: 15139056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B; Baekelandt M; Shih IeM
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Cadherin complex protein expression and survival in ovarian carcinoma.
    Davidson B; Gotlieb WH; Ben-Baruch G; Nesland JM; Bryne M; Goldberg I; Kopolovic J; Berner A
    Gynecol Oncol; 2000 Dec; 79(3):362-71. PubMed ID: 11104606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.